© 2025 Michigan State University Board of Trustees
Public Media from Michigan State University
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

TECHNOTE: Thu 9/4/25 Radio broadcast interruptions during tower work 9am-5pm

MSU pushes potential Parkinson's drug to clinical trial

Courtesy - Michigan State University

Neurodegenerative disorders such as Parkinson’s and Alzheimer’s cost the U-S billions of dollars each year. Last year, a study supported by the National Institutes of Health found that in 2010, the cost of treating Alzheimer’s alone neared $215-billion.These devastating illnesses also take a huge emotional toll on both the victims and their loved ones.

Current State’s Kevin Lavery reports that a team at Michigan State University is studying a protein molecule that it feels may become a new drug in the fight against degenerative diseases.

They say they’re ready to make the leap to clinical trials. 

Kevin Lavery served as a general assignment reporter and occasional local host for Morning Edition and All Things Considered before retiring in 2023.
Related Content
Together we’ve already reduced WKAR’s $1.6 million budget gap created by the loss of federal funding. With your sustaining support we can close the remaining $500,000 gap and keep trusted public media strong for mid-Michigan. The best way to support WKAR is to become a sustainer. Already a sustainer? Please consider upgrading your current monthly gift.